{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:00:19Z","timestamp":1740117619469,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007813","name":"Center for AIDS Research","doi-asserted-by":"crossref","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Maternal, Pediatric and Adolescent AIDS Clinical Trials Group","award":["UM1 AI106716"],"award-info":[{"award-number":["UM1 AI106716"]}]},{"name":"Global Fund to fight AIDS, TB and Malaria","award":["PRDDC-H-N-008\/SSF"],"award-info":[{"award-number":["PRDDC-H-N-008\/SSF"]}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"crossref","award":["R01HD 39615"],"award-info":[{"award-number":["R01HD 39615"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Agence Nationale de Recherches sur le Sida et les h\u00e9patites virales","award":["ANRS 12179"],"award-info":[{"award-number":["ANRS 12179"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jviromet.2016.03.014","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T11:28:47Z","timestamp":1459078127000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus"],"prefix":"10.1016","volume":"233","author":[{"given":"Ingrid A.","family":"Beck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Payant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ngo-Giang-Huong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woottichai","family":"Khamduang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laddawan","family":"Laomanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzague","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2016.03.014_bib0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/JCM.40.4.1413-1419.2002","article-title":"Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors","volume":"40","author":"Beck","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0010","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/JCM.00306-14","article-title":"Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing","volume":"52","author":"Beck","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0015","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QAI.0b013e3181967602","article-title":"National expansion of antiretroviral treatment in Thailand, 2000\u20132007: program scale-up and patient outcomes","volume":"50","author":"Chasombat","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0025","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/JCM.42.8.3670-3674.2004","article-title":"Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma","volume":"42","author":"Ellis","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jmv.21505","article-title":"Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B","volume":"81","author":"Iacomi","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/652148","article-title":"Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure","volume":"50","author":"Jourdain","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0045","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22796","article-title":"Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model","volume":"49","author":"Kamili","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0050","doi-asserted-by":"crossref","first-page":"e42184","DOI":"10.1371\/journal.pone.0042184","article-title":"Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand","volume":"7","author":"Khamduang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jcv.2013.06.025","article-title":"Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring","volume":"58","author":"Khamduang","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.26686","article-title":"No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B","volume":"59","author":"Kitrinos","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0070","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/JCM.00020-07","article-title":"Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay","volume":"45","author":"Libbrecht","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3851\/IMP1499","article-title":"Molecular genesis of drug-resistant and vaccine-escape HBV mutants","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-015-0053-z","article-title":"Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand","volume":"12","author":"Manosuthi","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/597808","article-title":"Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients","volume":"199","author":"Margeridon-Thermet","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0095","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/652151","article-title":"Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine","volume":"50","author":"Micek","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.antiviral.2008.10.008","article-title":"Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir","volume":"81","author":"Seifer","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/aid.2011.0131","article-title":"Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru","volume":"28","author":"Soria","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0115","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1128\/JCM.37.9.3013-3016.1999","article-title":"Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus","volume":"37","author":"Thibault","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.2001.1246","article-title":"Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy","volume":"293","author":"Torresi","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","article-title":"Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient","volume":"39","author":"Villeneuve","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0130","article-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"WHO","year":"2015","journal-title":"Geneva"},{"key":"10.1016\/j.jviromet.2016.03.014_bib0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.hepres.2005.12.007","article-title":"A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus","volume":"34","author":"Xiao","year":"2006","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jviromet.2016.03.014_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3851\/IMP1552","article-title":"Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy","volume":"15","author":"Yeh","year":"2010","journal-title":"Antivir. Ther."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093416300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093416300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T20:58:08Z","timestamp":1600376288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093416300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":28,"alternative-id":["S0166093416300490"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.03.014","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}